- Liquidia Corporation | Corporate Website
Liquidia develops innovative therapies for pulmonary hypertension using PRINT® Technology, including YUTREPIA™, an inhalation powder for PAH and PH-ILD
- Careers | Liquidia Corporation
Explore career opportunities at Liquidia Corporation, a company dedicated to innovation in pulmonary and other diseases
- Investors | Liquidia Corporation
Explore Liquidia Corporation's investor resources, financial updates, and corporate information for insights into their innovative therapies and business strategies
- Stock quote chart | Liquidia Corporation
Stay updated with Liquidia Corporation's stock performance through real-time quotes and interactive charts for informed investment decisions
- Liquidia Corporation to Report Full Year 2022 Financial Results on . . .
MORRISVILLE, N C , March 09, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its full year 2022 financial results on Thursday, March 16, 2023 The company will host a webcast at 8:30 a m Eastern Time to discuss financial results and provide a corporate update
|